Navigation Links
Genzyme Announces Results of Clinical Trial of Hylastan

imary endpoint of demonstrating that hylastan provides superior pain relief to steroids. The safety profile of the three treatment arms appeared to be comparable in the preliminary analysis of the study results.

"We structured our development program in a way that provided us with several chances to reach our goal of introducing a single-injection product," said Ann Merrifield, president of Genzyme Biosurgery, the business unit that manufactures and markets Synvisc. "It is now clear that we will focus our efforts on bringing Synvisc-One to the market. We are confident that simplifying the treatment process will encourage a greater number of physicians and patients to seek the benefits of viscosupplementation to help manage OA knee pain. We will continue to analyze the findings from the hylastan study to determine how this product fits into our longer-range strategy, as we continue to invest in bringing innovation to this field."

About Genzyme

One of the world's leading biotechnology companies, Genzyme is dedicated to making a major positive impact on the lives of people with serious diseases. Since 1981, the company has grown from a small start-up to a diversified enterprise with more than 9,000 employees in locations spanning the globe and 2006 revenues of $3.2 billion. Genzyme has been selected by FORTUNE as one of the "100 Best Companies to Work for" in the United States.

With many established products and services helping patients in nearly 90 countries, Genzyme is a leader in the effort to develop and apply the most advanced technologies in the life sciences. The company's products and services are focused on rare inherited disorders, kidney disease, orthopaedics, cancer, transplant, and diagnostic testing. Genzyme's commitment to innovation continues today with a substantial development program focused on these fields, as well as immune disease, infectious disease, and other areas of unmet medical need.

This press release con
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
2. Genzyme Announces Results of Clinical Trials Investigating Powder Form of Sevelamer Carbonate
3. Genzyme Announces Results of Clinical Trials Investigating Powder Form of Sevelamer Carbonate
4. Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year Alemtuzumab in Multiple Sclerosis Data Presented at AAN
5. Genzyme Announces Successful Completion of Study Investigating Sevelamer Carbonate in Patients With Chronic Kidney Disease
6. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
7. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
9. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
10. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
11. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Genzyme Announces Results Clinical Trial Hylastan
(Date:8/21/2014)... , Aug. 21, 2014  ACI Clinical ( ... independent Data Monitoring Committees. Using this ... percent over industry standard costs and receive the ... leader in committee services. Leveraging a ... and contracting, charter development, statistical programming and meeting ...
(Date:8/21/2014)... , Aug. 21, 2014 CVS Caremark Corporation ... results, applicable Reference Yields and consideration payable in connection with ... on August 7, 2014 for (1) any and all of ... Notes") and (2) up to a maximum amount of its ... and 5.750% Senior Notes due 2017 (collectively, the "Maximum Tender ...
(Date:8/21/2014)... Aug. 21, 2014  Cyberonics, Inc. (NASDAQ: CYBX ... 2014.  Quarterly highlights 1   ... to the first quarter of fiscal 2014, and other achievements, ... an increase of 6.8%; , Strong international net sales ... currency basis; , U.S. net product sales reached a ...
Breaking Medicine Technology:ACI Clinical: Innovation and Savings in Data Safety Monitoring Committees 2CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 2CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 3CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 4CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 5CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 6Cyberonics Reports Fiscal 2015 First Quarter Results 2Cyberonics Reports Fiscal 2015 First Quarter Results 3Cyberonics Reports Fiscal 2015 First Quarter Results 4Cyberonics Reports Fiscal 2015 First Quarter Results 5Cyberonics Reports Fiscal 2015 First Quarter Results 6Cyberonics Reports Fiscal 2015 First Quarter Results 7Cyberonics Reports Fiscal 2015 First Quarter Results 8Cyberonics Reports Fiscal 2015 First Quarter Results 9Cyberonics Reports Fiscal 2015 First Quarter Results 10Cyberonics Reports Fiscal 2015 First Quarter Results 11Cyberonics Reports Fiscal 2015 First Quarter Results 12Cyberonics Reports Fiscal 2015 First Quarter Results 13Cyberonics Reports Fiscal 2015 First Quarter Results 14Cyberonics Reports Fiscal 2015 First Quarter Results 15Cyberonics Reports Fiscal 2015 First Quarter Results 16
... A combination of three drugs used worldwide as the standard ... danger of death or hospitalization, and should not be used ... to the surprising results of a rigorous independent study. ... the New England Journal of Medicine to coincide ...
... /PRNewswire-iReach/ -- Denton Vacuum LLC, a leading ... new website that guides visitors to information ... and navigation mirror what it,s like to work with ... business and technical drivers," says Rod Moore, Denton,s president. ...
Cached Medicine Technology:First, do no harm: Study finds danger in standard treatment for a serious lung disease 2First, do no harm: Study finds danger in standard treatment for a serious lung disease 3First, do no harm: Study finds danger in standard treatment for a serious lung disease 4Denton Vacuum's New Website Organizes Thin-Film Technology Information By Industry 2
(Date:8/22/2014)... FastFingerprints is adding a new location to ... Wednesday, August 27, 2014 and is located at 3740 ... the addition of this new office, that will bring ... Cleveland area. Our new Cleveland-Midtown location will provide ... hours of operation will be Monday-Friday 8:00am – 5:00pm ...
(Date:8/22/2014)... Dealing with a drug or alcohol addiction is ... a child. Adolescent substance abuse has been an important issue ... a new helpline is now providing a valuable resource for ... something like a teen drug addiction . , ... a positive impact in the community. By calling (513) 318-1603, ...
(Date:8/22/2014)... According to the market research report "Blind ... (ACC) System Market for Passenger Cars; by Geography ... by MarketsandMarkets, classifies and defines the automotive BSD ... and value. The report highlights potential growth opportunities ... review of the market drivers, restrains, growth indicators, ...
(Date:8/21/2014)... August 22, 2014 The natural loss of ... lines, wrinkles and sagging of skin. Using products to ... age 40, the body has lost about 15% of it ... 45%," says Kathy Heshelow, founder of Sublime Beauty®. "Collagen ... it - well, we know what happens." , Collagen in ...
(Date:8/21/2014)... New York, NY (PRWEB) August 21, 2014 ... policies can often have larger discounts for specific protection ... company is now helping consumers to quote life insurance ... . , The local agents that appear inside ... to offer a fast method of price reviews this ...
Breaking Medicine News(10 mins):Health News:FastFingerprints Expands In The Cleveland Ohio Area 2Health News:FastFingerprints Expands In The Cleveland Ohio Area 3Health News:Cincinnati’s New Troubled Teen Helpline is Making a Difference in the Community 2Health News:Automotive Blind Spot Detection System Market Worth $2.8 Billion and Automotive Adaptive Cruise Control System Market Worth $6.1 Billion by 2019 – New Report 2Health News:Automotive Blind Spot Detection System Market Worth $2.8 Billion and Automotive Adaptive Cruise Control System Market Worth $6.1 Billion by 2019 – New Report 3Health News:Automotive Blind Spot Detection System Market Worth $2.8 Billion and Automotive Adaptive Cruise Control System Market Worth $6.1 Billion by 2019 – New Report 4Health News:4 Skincare Products That Boost and Nurture Collagen on Sale at Sublime Beauty® 2Health News:4 Skincare Products That Boost and Nurture Collagen on Sale at Sublime Beauty® 3Health News:Life Insurance from Local Agents Now Priced Nationally Through Complimentary Tool Online 2
... who were treated with male hormone suppression therapy and ... to high levels of other illnesses did not experience ... 23 issue of JAMA. , Several studies have documented ... (AST) is combined with external beam radiation therapy (RT) ...
... American Heart Month, which is just ahead in February, ... and Prevention (CDC) shows that, since 1999, coronary heart ... 25.8 percent and 24.4 percent, respectively. This means ... reducing deaths from coronary heart disease has been achieved, ...
... in African-American and Caucasian men, researchers reported in Circulation: ... Veterans Affairs study included 15,660 participants and is the ... mortality. , It is important to emphasize that it ... brisk walking to attain the associated health benefits. ...
... a patients risk for heart disease, stroke and other ... could gauge risk of overall ,or global, CVD and ... to a study published in Circulation: Journal of the ... well suited for use by office-based primary care physicians, ...
... Leger Joins Agency as Executive Vice President, Managing Director, ... a leading healthcare,communications network, announced that Marcy Leger has ... Euro RSCG Life LM&P New,York, as a result of ... David Paragamian, Partner, President of Euro RSCG Life LM&P ...
... HEIGHTS, Mich., Jan. 22 On February 18, ... at 33045 Hamilton Court,Farmington Hills, Michigan. The Farmington ... an intimate, small campus, community-style setting.,This approximately 7,500 ... offering morning, afternoon and evening classes in medical,assisting ...
Cached Medicine News:Health News:Combination therapy improves survival for certain prostate cancer patients 2Health News:Heart and stroke death rates steadily decline; risks still too high 2Health News:Heart and stroke death rates steadily decline; risks still too high 3Health News:Heart and stroke death rates steadily decline; risks still too high 4Health News:Daily exercise dramatically lowers men's death rates 2Health News:Daily exercise dramatically lowers men's death rates 3Health News:A simplified scoring system may predict overall CVD risk, individual CVD components risk 2Health News:Euro RSCG Life LM&P Announces Growth of Leadership Team 2Health News:Dorsey Schools, Detroit Area's Preeminent Career Training School, Opens a Fifth Campus in Farmington Hills 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: